Skip to main content

Table 5 Changes in FVC at Week 48 by decile of predicted emphysema extent (clinical trial cohort)

From: A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema

Decile of predicted emphysema extent

N

Median predicted emphysema extent, %

Mean (SD) FVC, L

Change in mean (SD) FVC from baseline

Relative, %

Absolute, L

Total

455

8.4

2.80 (0.78)

–5.4 (12.1)

–0.14 (0.34)

1st

45

–4.5

2.48 (0.68)

–5.7 (14.2)

–0.12 (0.32)

2nd

46

0.3

2.57 (0.69)

–5.5 (12.3)

–0.15 (0.32)

3rd

45

3.1

2.72 (0.81)

–8.8 (13.1)

–0.22 (0.34)

4th

46

5.3

2.65 (0.69)

–4.9 (11.5)

–0.15 (0.31)

5th

45

7.6

2.67 (0.50)

–7.0 (9.5)

–0.18 (0.23)

6th

46

9.2

2.76 (0.76)

–4.6 (12.8)

–0.12 (0.32)

7th

46

11.3

2.74 (0.71)

–6.2 (12.8)

–0.15 (0.68)

8th

45

13.4

3.03 (0.87)

–7.6 (9.6)

–0.23 (0.30)

9th

46

15.9

3.12 (0.90)

–2.6 (10.2)

–0.07 (0.34)

10th

45

21.0

3.21 (0.80)

–0.8 (12.7)

–0.02 (0.46)

  1. Relative (%) and absolute (L) changes in FVC from baseline at Week 48 for patients with IPF, with and without emphysema, in the clinical trial cohort (N = 455) by decile of predicted emphysema extent
  2. FVC forced vital capacity; IPF idiopathic pulmonary fibrosis; SD standard deviation